fenoldopam and acetylcysteine

fenoldopam has been researched along with acetylcysteine in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's21 (80.77)29.6817
2010's5 (19.23)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Allaqaband, S; Bajwa, TK; Gupta, A; Malik, AM; Shalev, Y; Tumuluri, R; Volkert, P1
Brinker, JA1
Lepor, NE2
King, SL; Thompson, EJ1
Brokering, KL; Theobald, JC; Walker, PD1
Morcos, SK1
Asif, A; Epstein, M1
Airoldi, F; Balestrieri, P; Briguori, C; Castelli, A; Colombo, A; Focaccio, A; Golia, B; Lepore, S; Librera, M; Paolo Elia, P; Ricciardelli, B; Riviezzo, G; Scarpato, P; Violante, A1
Kellum, J; Leblanc, M; Venkataraman, R3
Itoh, Y; Oishi, R; Sendo, T; Yano, T1
Cieciorka, M; Ineck, BA; Kline, ME; Ng, TM; Nissen, LR; O'Leary, EL; Porter, LL; Puumala, SE; Rigmaiden, RS; Shurmur, SW; Silver, M1
de Fijter, C; Schultz, MJ; Smit, W; Tonino, S; van den Berk, G1
Kolarz, M; Sułowicz, W1
Pannu, N; Tonelli, M1
Mehran, R1
Dangas, G; Mehran, R; Pucelikova, T1
Barr, LF; Kolodner, K1
Kellum, JA; Leblanc, M; Venkataraman, R1
Caixeta, A; Mehran, R1
Corona, D; Cutuli, M; Molino, C; Morello, G; Pappalardo, R; Parrinello, L; Rinzivillo, D; Sorbello, M; Veroux, M; Veroux, P1
Nahl, D; Rundback, JH; Yoo, V1
Briguori, C; Condorelli, G; Donnarumma, E; Fiore, D; Quintavalle, C1

Reviews

20 review(s) available for fenoldopam and acetylcysteine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
    Reviews in cardiovascular medicine, 2003, Volume: 4 Suppl 1

    Topics: Acetylcysteine; Animals; Contrast Media; Diabetes Complications; Dogs; Dopamine Agonists; Evaluation Studies as Topic; Fenoldopam; Fluid Therapy; Free Radical Scavengers; Humans; Ischemia; Kidney Diseases; Kidney Tubules; Models, Animal

2003
Acetylcysteine and fenoldopam. Promising new approaches for preventing effects of contrast nephrotoxicity.
    Critical care nurse, 2003, Volume: 23, Issue:3

    Topics: Acetylcysteine; Antioxidants; Contrast Media; Drug Administration Routes; Drug Administration Schedule; Fenoldopam; Humans; Renal Insufficiency; Risk Factors; Vasodilator Agents

2003
A review of pharmacologic interventions to prevent contrast-induced nephropathy.
    Reviews in cardiovascular medicine, 2003, Volume: 4 Suppl 5

    Topics: Acetylcysteine; Adenosine; Calcium Channel Blockers; Contrast Media; Creatinine; Fenoldopam; Furosemide; Hemodynamics; Humans; Kidney Diseases; Mannitol; Prostaglandins

2003
Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.
    Pharmacotherapy, 2003, Volume: 23, Issue:12

    Topics: Acetylcysteine; Contrast Media; Dopamine Agonists; Fenoldopam; Free Radical Scavengers; Humans; Ischemia; Kidney; Kidney Diseases; Randomized Controlled Trials as Topic

2003
Prevention of contrast media nephrotoxicity--the story so far.
    Clinical radiology, 2004, Volume: 59, Issue:5

    Topics: Acetylcysteine; Alprostadil; Atrial Natriuretic Factor; Contrast Media; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Fenoldopam; Hemofiltration; Humans; Kidney Diseases; Renal Dialysis; Risk Factors; Vasodilator Agents

2004
Prevention of radiocontrast-induced nephropathy.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 44, Issue:1

    Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Creatinine; Fenoldopam; Hemofiltration; Humans; Renal Dialysis; Ultrafiltration

2004
Acute renal failure.
    Clinical evidence, 2003, Issue:10

    Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Calcium Channel Blockers; Diuretics; Dopamine; Dopamine Agonists; Fenoldopam; Fluid Therapy; Humans; Mannitol; Renal Replacement Therapy; Theophylline

2003
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
    Journal of pharmacological sciences, 2005, Volume: 97, Issue:4

    Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atrial Natriuretic Factor; Contrast Media; Diuretics; Endothelins; Epoprostenol; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Iodine Radioisotopes; Kidney Tubules; Models, Biological; Renal Dialysis; Risk Factors

2005
Acute renal failure.
    Clinical evidence, 2005, Issue:13

    Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Calcium Channel Blockers; Diuretics, Osmotic; Dopamine; Fenoldopam; Fluid Therapy; Humans; Mannitol; Natriuretic Peptides; Renal Dialysis; Renal Replacement Therapy; Sodium Potassium Chloride Symporter Inhibitors; Theophylline

2005
Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
    Critical care (London, England), 2005, Volume: 9, Issue:4

    Topics: Acetylcysteine; Contrast Media; Critical Care; Fenoldopam; Free Radical Scavengers; Hemofiltration; Humans; Kidney Diseases; Sodium Bicarbonate; Theophylline; Treatment Outcome; Vasodilator Agents

2005
[Nephropathy caused by radiocontrast media].
    Przeglad lekarski, 2005, Volume: 62, Issue:5

    Topics: Acetylcysteine; Acute Kidney Injury; Clinical Trials as Topic; Contrast Media; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Isotonic Solutions; Kidney Tubules; Radiopharmaceuticals

2005
Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.
    Current opinion in nephrology and hypertension, 2006, Volume: 15, Issue:3

    Topics: Acetylcysteine; Ascorbic Acid; Contrast Media; Evidence-Based Medicine; Fenoldopam; Humans; Kidney Diseases; Osmolar Concentration; Risk Factors; Theophylline

2006
Renal failure (acute).
    Clinical evidence, 2006, Issue:15

    Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Aminophylline; Amphotericin B; Calcium Channel Blockers; Diuretics, Osmotic; Dopamine; Fenoldopam; Fluid Therapy; Humans; Mannitol; Natriuretic Peptides; Renal Dialysis; Renal Replacement Therapy; Theophylline

2006
Contrast-induced nephropathy remains a serious complication of PCI.
    Journal of interventional cardiology, 2007, Volume: 20, Issue:3

    Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Disease Progression; Fenoldopam; Humans; Incidence; Kidney Diseases; Prognosis; Risk Factors; Sodium Bicarbonate

2007
Contrast-induced nephropathy.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Jan-01, Volume: 71, Issue:1

    Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Fenoldopam; Free Radical Scavengers; Heart Failure; Humans; Iatrogenic Disease; Kidney Diseases; Kidney Transplantation; Multivariate Analysis; Osmolar Concentration; Phosphodiesterase Inhibitors; Prognosis; Renal Dialysis; Risk Factors; Theophylline

2008
Acute renal failure.
    BMJ clinical evidence, 2008, Sep-03, Volume: 2008

    Topics: Acetylcysteine; Acute Kidney Injury; Fenoldopam; Humans; Renal Dialysis; Renal Insufficiency; Renal Replacement Therapy

2008
Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Mar-01, Volume: 75 Suppl 1

    Topics: Acetylcysteine; Acute Disease; Angioplasty, Balloon, Coronary; Contrast Media; Dopamine; Drug Administration Routes; Evidence-Based Medicine; Fenoldopam; Fluid Therapy; Humans; Kidney Diseases; Patient Selection; Practice Guidelines as Topic; Protective Agents; Radiography, Interventional; Risk Assessment; Risk Factors; Sodium Bicarbonate; Treatment Outcome

2010
Contrast-induced nephropathy.
    Journal of vascular surgery, 2011, Volume: 54, Issue:2

    Topics: Acetylcysteine; Antioxidants; Contrast Media; Evidence-Based Medicine; Fenoldopam; Fluid Therapy; Humans; Kidney Diseases; Risk Assessment; Risk Factors; Treatment Outcome; Vasodilator Agents

2011
Therapeutic strategies to prevent contrast-induced acute kidney injury.
    Current opinion in cardiology, 2013, Volume: 28, Issue:6

    Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Calcium Channel Blockers; Contrast Media; Diuretics; Dopamine; Fenoldopam; Fluid Therapy; Furosemide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Treatment Outcome; Vasodilator Agents

2013

Trials

4 trial(s) available for fenoldopam and acetylcysteine

ArticleYear
Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2002, Volume: 57, Issue:3

    Topics: Acetylcysteine; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Contrast Media; Coronary Angiography; Creatinine; Female; Fenoldopam; Free Radical Scavengers; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sodium Chloride; Stroke Volume; Treatment Outcome

2002
N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
    Journal of the American College of Cardiology, 2004, Aug-18, Volume: 44, Issue:4

    Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinine; Dopamine Agonists; Drug Administration Schedule; Female; Fenoldopam; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Male

2004
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
    International journal of cardiology, 2006, May-24, Volume: 109, Issue:3

    Topics: Acetylcysteine; Adult; Aged; Cardiac Catheterization; Contrast Media; Female; Fenoldopam; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Prospective Studies

2006
N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
    Critical care medicine, 2008, Volume: 36, Issue:5

    Topics: Acetylcysteine; Aged; Cardiac Surgical Procedures; Dopamine Agonists; Double-Blind Method; Female; Fenoldopam; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Postoperative Complications; Prospective Studies

2008

Other Studies

2 other study(ies) available for fenoldopam and acetylcysteine

ArticleYear
The third strike.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2002, Volume: 57, Issue:3

    Topics: Acetylcysteine; Antihypertensive Agents; Cardiovascular Diseases; Contrast Media; Fenoldopam; Free Radical Scavengers; Humans; Kidney Diseases; Radiopharmaceuticals; Sodium Chloride

2002
Effect of N-acetyl-cysteine (NAC) added to fenoldopam or dopamine on end-tidal carbon dioxide and mean arterial pressure at time of renal artery declamping during cadaveric kidney transplantation.
    Transplantation proceedings, 2010, Volume: 42, Issue:4

    Topics: Acetylcysteine; Adult; Aged; Antihypertensive Agents; Antioxidants; Blood Pressure; Cadaver; Carbon Dioxide; Dopamine; Dopamine Agents; Female; Fenoldopam; Humans; Kidney Transplantation; Male; Middle Aged; Renal Artery; Retrospective Studies; Tidal Volume; Tissue Donors

2010